These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12722628)

  • 1. [Prospects of the use of non-ionic X-ray contrast media during endoscopic retrograde cholangiopancreatography].
    Sviridov NK; Napolov IuK
    Vestn Rentgenol Radiol; 2002; (6):62-3. PubMed ID: 12722628
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prospects of the use of non-ionic X-ray contrast substances during endoscopic retrograde cholangiopancreatography].
    Sviridov NK; Napolov IuK
    Vestn Rentgenol Radiol; 2003; (6):62-3. PubMed ID: 14674360
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial.
    Goebel C; Hardt P; Doppl W; Temme H; Hackstein N; Klör HU
    Eur Radiol; 2000; 10(4):677-80. PubMed ID: 10795554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Cotton PB; Brazer SR
    Am J Gastroenterol; 1992 May; 87(5):683; author reply 684-5. PubMed ID: 1595670
    [No Abstract]   [Full Text] [Related]  

  • 5. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Banerjee A
    Am J Gastroenterol; 1992 May; 87(5):683-4; author reply 684-5. PubMed ID: 1595671
    [No Abstract]   [Full Text] [Related]  

  • 7. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Short TP; Thomas E
    Am J Gastroenterol; 1992 May; 87(5):682-3; author reply 684-5. PubMed ID: 1595669
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model.
    Pfau PR; Mosley RG; Said A; Gopal DV; Fischer MC; Oberley T; Weiss J; Lee FT; Eckoff D; Reichelderfer M
    JOP; 2006 Jan; 7(1):27-33. PubMed ID: 16407615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria following nephroangiography. VII. Comparison between ionic monomeric, monoacidic dimeric and non-ionic contrast media in the dog.
    Törnquist C; Almén T; Golman K; Holtås S
    Acta Radiol Suppl; 1980; 362():49-52. PubMed ID: 6267893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic quality in endoscopic retrograde cholangiopancreatography: comparison between lodixanol and lopromide.
    Martin DF; England RE; Rösch T; Biehl E; Jeschke B; Heldwein D; Klauser A; Klaveness A; Kristoffersen D
    Endoscopy; 2000 Oct; 32(10):783-7. PubMed ID: 11068838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iopromide, a new contrast medium for angiography. Clinical study and comparison with other low-osmolar contrast media].
    Steidle B; Wolf KJ; Banzer D; Seyferath W
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1275-8. PubMed ID: 6381018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of non-ionic X-ray contrast media after intracisternal administration in rats.
    Wible JH; Barco SJ; Scherrer DE; Wojdyla JK; Adams MD
    Eur J Radiol; 1995 Mar; 19(3):206-11. PubMed ID: 7601172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cytotoxicity of low-osmolar nonionic and high-osmolar ionic contrast media to dog gallbladder epithelial cells.
    Ju YM; Kim MH; Lee SK; Seo DW; Min YI; Kim JY
    Gastrointest Endosc; 2002 Mar; 55(3):382-6. PubMed ID: 11868013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immediate effects of retrograde pancreatography on the pancreas.
    Kivisaari L; Alitalo I
    Eur J Radiol; 1984 Feb; 4(1):58-60. PubMed ID: 6723675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic effectiveness and safety of currently available X-ray contrast media].
    Sergeev PV; Sviridov NK; Poliaev IuA; Shimanovskiĭ NL
    Vestn Rentgenol Radiol; 1999; (6):45-9. PubMed ID: 10714233
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrotoxicity of low-osmolar and iso-osmolar contrast media.
    Heinrich M; Uder M
    Kidney Int; 2006 Mar; 69(6):1095. PubMed ID: 16528264
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacology of nonionic roentgen contrast media].
    Turnheim K
    Wien Klin Wochenschr; 1986 May; 98(11):333-8. PubMed ID: 3727593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences with rayvist and iopromid in head and body CT.
    Zeitler E; Böhnlein K; Gailer H; Lindner R; Richter EI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():162-72. PubMed ID: 6139073
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the effects of noniodinized and iodinized ionic contrast media and gadoteric acid in acute necrotizing pancreatitis: experimental study in rabbits.
    Apodaca-Torrez FR; Goldenberg A; Lobo EJ; Farah JF; Triviño T; Montero EF; Schraibman V; Benvenuto RB; Artigiani Neto R
    Pancreas; 2007 Nov; 35(4):e41-4. PubMed ID: 18090230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid function, thyroid immunoglobulin status, and urinary iodine excretion after enteral contrast-agent administration by endoscopic retrograde cholangiopancreatography.
    Fassbender WJ; Vogel C; Doppl W; Stracke H; Bretzel RG; Klör HU
    Endoscopy; 2001 Mar; 33(3):245-52. PubMed ID: 11293758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.